Convergene LLC
3093 Beverly Ln
Cambridge, MD 21613
Convergene LLC, located in Cambridge, MD, specializes in the development of first-in-class dual inhibitors that target both BET bromodomains and dopamine receptor 2. Their innovative approach aims to address the treatment of rare diseases through cutting-edge pharmaceutical solutions.
Founded in 2017, Convergene LLC is committed to advancing healthcare by focusing on unique therapeutic strategies that combine multiple targets for enhanced efficacy. The company’s dedication to research and development positions it at the forefront of biopharmaceutical innovation.
Generated from the website
Also at this address
See a problem?
You might also like
Partial Data by Infogroup (c) 2025. All rights reserved.